The decision addresses the recovery of VAT on payments made under loan cover provided free of charge.
Read more
The announcement by the Council for Medical Schemes (CMS) that no primary health insurance plans and low-cost benefit packages would be permitted after March 2021 was met by severe criticism from the industry. […]
The announcement by the Council for Medical Schemes (CMS) that no primary health insurance plans and low-cost benefit packages would be permitted after March 2021 was met by severe criticism from the industry. […]
Towards the end of 2019, the Council for Medical Schemes (CMS) published two circulars announcing its future plans for Low Cost Benefit Options (LCBO) and the Demarcation Exemption Framework. The timing and one-sidedness […]
The Financial Intermediaries Association (FIA) also responded to the announcement of the Council for Medical Schemes (CMS) prohibiting South African medical aids from offering Low-Cost Benefit Options (LCBO) to low-income market segments. The […]
Towards the end of last year, the Council for Medical Schemes (CMS) published two circulars announcing its plans for Low Cost Benefit Options (LCBO) and the Demarcation Exemption Framework, going forward. Basically, the […]
The Council for Medical Schemes (CMS) has published a circular in which it prohibits South African medical aids from offering Low-Cost Benefit Options (LCBO) to low-income market segments. Furthermore, no products based on […]
In September 2018, the Council for Medical Schemes (CMS) published a Draft Framework for Medical Schemes Consolidation for comment. In response to these comments the CMS has done additional analysis and as a […]
The current exemption of indemnity products that are doing the business of a medical scheme expires on 31 March 2019. Entities that were granted exemption on their indemnity products in 2017, should submit renewal applications, […]
Under the heading, Discovery may go to court after CMS bans products, Legalbrief Today reports as follows: “Discovery Health (Pty) Ltd may turn to litigation after the Final Board of Appeal of the […]
